Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants

被引:41
|
作者
Qu, Panke [1 ]
Faraone, Julia N. [1 ]
Evans, John P. [1 ]
Zheng, Yi-Min [1 ]
Yu, Lianbo [1 ]
Ma, Qin [1 ]
Carlin, Claire [1 ]
Lozanski, Gerard [1 ]
Saif, Linda J. [1 ]
Oltz, Eugene M. [1 ]
Gumina, Richard J. [1 ]
Liu, Shan-Lu [1 ]
机构
[1] Ohio State Univ, Columbus, OH 43210 USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2022年 / 387卷 / 14期
关键词
D O I
10.1056/NEJMc2210546
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1329 / 1331
页数:3
相关论文
共 50 条
  • [1] Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5
    Qian Wang
    Yicheng Guo
    Sho Iketani
    Manoj S. Nair
    Zhiteng Li
    Hiroshi Mohri
    Maple Wang
    Jian Yu
    Anthony D. Bowen
    Jennifer Y. Chang
    Jayesh G. Shah
    Nadia Nguyen
    Zhiwei Chen
    Kathrine Meyers
    Michael T. Yin
    Magdalena E. Sobieszczyk
    Zizhang Sheng
    Yaoxing Huang
    Lihong Liu
    David D. Ho
    [J]. Nature, 2022, 608 : 603 - 608
  • [2] Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5
    Hachmann, Nicole P.
    Miller, Jessica
    Collier, Ai-ris Y.
    Ventura, John D.
    Yu, Jingyou
    Rowe, Marjorie
    Bondzie, Esther A.
    Powers, Olivia
    Surve, Nehalee
    Hall, Kevin
    Barouch, Dan H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (01): : 86 - 88
  • [3] Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5
    Wang, Qian
    Guo, Yicheng
    Iketani, Sho
    Nair, Manoj S.
    Li, Zhiteng
    Mohri, Hiroshi
    Wang, Maple
    Yu, Jian
    Bowen, Anthony D.
    Chang, Jennifer Y.
    Shah, Jayesh G.
    Nguyen, Nadia
    Chen, Zhiwei
    Meyers, Kathrine
    Yin, Michael T.
    Sobieszczyk, Magdalena E.
    Sheng, Zizhang
    Huang, Yaoxing
    Liu, Lihong
    Ho, David D.
    [J]. NATURE, 2022, 608 (7923) : 603 - +
  • [4] Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants
    Qu, Panke
    Faraone, Julia
    Evans, John P.
    Zou, Xue
    Zheng, Yi-Min
    Carlin, Claire
    Bednash, Joseph S.
    Lozanski, Gerard
    Mallampalli, Rama K.
    Saif, Linda J.
    Oltz, Eugene M.
    Mohler, Peter J.
    Gumina, Richard J.
    Liu, Shan-Lu
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (26): : 2526 - +
  • [5] Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
    Hung Fu Tseng
    Bradley K. Ackerson
    Katia J. Bruxvoort
    Lina S. Sy
    Julia E. Tubert
    Gina S. Lee
    Jennifer H. Ku
    Ana Florea
    Yi Luo
    Sijia Qiu
    Soon Kyu Choi
    Harpreet S. Takhar
    Michael Aragones
    Yamuna D. Paila
    Scott Chavers
    Carla A. Talarico
    Lei Qian
    [J]. Nature Communications, 14
  • [6] Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
    Tseng, Hung Fu
    Ackerson, Bradley K.
    Bruxvoort, Katia J.
    Sy, Lina S.
    Tubert, Julia E.
    Lee, Gina S.
    Ku, Jennifer H.
    Florea, Ana
    Luo, Yi
    Qiu, Sijia
    Choi, Soon Kyu
    Takhar, Harpreet S.
    Aragones, Michael
    Paila, Yamuna D.
    Chavers, Scott
    Talarico, Carla A.
    Qian, Lei
    [J]. NATURE COMMUNICATIONS, 2023, 14 (01)
  • [7] Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants
    Takashita, Emi
    Yamayoshi, Seiya
    Simon, Viviana
    Van Bakel, Harm
    Sordillo, Emilia M.
    Pekosz, Andrew
    Fukushi, Shuetsu
    Suzuki, Tadaki
    Maeda, Ken
    Halfmann, Peter
    Sakai-Tagawa, Yuko
    Ito, Mutsumi
    Watanabe, Shinji
    Imai, Masaki
    Hasegawa, Hideki
    Kawaoka, Yoshihiro
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (05): : 468 - 470
  • [8] Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5
    Arora, Prerna
    Kempf, Amy
    Nehlmeier, Inga
    Schulz, Sebastian R.
    Cossmann, Anne
    Stankov, Metodi V.
    Jaeck, Hans-Martin
    Behrens, Georg M. N.
    Pohlmann, Stefan
    Hoffmann, Markus
    [J]. LANCET INFECTIOUS DISEASES, 2022, 22 (08): : 1117 - 1118
  • [9] Implications of the SARS-CoV-2 subvariants BA.4 and BA.5
    Rahimi, Farid
    Abadi, Amin Talebi Bezmin
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2022, 104
  • [10] Commentary on 'Implications of the SARS-CoV-2 subvariants BA.4 and BA.5'
    Khani, Elnaz
    Entezari-Maleki, Taher
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (01) : 75 - 76